Riskpilot← Back to searchSign inGet full accessÅROS APOTEK AS
ASActiveOrg 926358766Hurumveien 49A, 3474 ÅrosRetail sale of pharmaceutical products · NACE 4773Est. 20215 employees
Revenue 2024
NOK 10,4M
+14% vs 2023
EBITDA margin
7.4%
+12% vs 2023
Equity ratio
31.3%
Financial strength
Net profit 2024
NOK 501K
-7% vs 2023
| Revenue | NOK 10,4M | +14% |
| EBITDA | NOK 774K | +12% |
| Net profit | NOK 501K | -7% |
| Total assets | NOK 2,9M | +23% |
| Equity | NOK 916K | +121% |
| Employees | 5 | — |
Legal name
ÅROS APOTEK AS
Org number
926358766
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
11. januar 2021
Share capital
NOK 400 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av apotekvarer.
Address
Hurumveien 49A, 3474 Åros
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 5 996 | 7 906 | 9 105 | 10 412 |
| Staff expenses | −0 | −968 | −1 637 | −959 | −1 265 |
| EBITDA | 0 | 83 | −348 | 691 | 774 |
| Depreciation & amort. | −0 | −93 | −88 | −84 | −81 |
| EBIT | 0 | −10 | −436 | 607 | 693 |
| Net financials | 0 | −27 | −39 | −60 | −47 |
| Profit before tax | 0 | −37 | −475 | 547 | 646 |
| Tax | −0 | −0 | −0 | 10 | 145 |
| Net profit | 0 | −37 | −475 | 537 | 501 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 400 | 3 339 | 2 258 | 2 385 | 2 927 |
| Equity | 390 | 353 | −122 | 415 | 916 |
| Long-term debt | 0 | 893 | 750 | 607 | 464 |
| Short-term debt | 10 | 2 093 | 1 631 | 1 363 | 1 547 |
| Total debt | 10 | 2 986 | 2 381 | 1 971 | 2 012 |
EBITDA margin
7.4%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
31.3%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
54.7%
This company
18.4%
Market median
+197% vs market
20202024
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20202024
Asset turnover
3.56×
This company
1.12×
Market median
+218% vs market
20202024
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RA Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Chairman | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2023 | |
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kambou Holding As
ÅROS APOTEK AS Board members of ÅROS APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Razan Abdulbaki Alsady | Chief Executive Officer | 0 companies |
| Basel Adi | Chairman | 0 companies |
| Fares Abbas Alfares | Chairman | 0 companies |
| Omar Abdulbaki Alsady | Board of Directors | 0 companies |
| Hamid Mahmood | Chairman | 0 companies |